Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.00
Bid: 35.80
Ask: 36.45
Change: -0.425 (-1.16%)
Spread: 0.65 (1.816%)
Open: 37.00
High: 37.40
Low: 35.25
Prev. Close: 36.55
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Thu, 04th Mar 2021 11:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Futura Medical, up 22% at 20.08 pence, 12-month range 7.16p-24.49p. The pharmaceutical company says it has entered into financing transactions with HT Riverwood Multi-Growth Fund which will provide the company with up to GBP2 million in cash, GBP1.5 million of which has been received.

----------

Franchise Brands, up 7.7% at 109.30p, 12-month range 81p-136.65p. Says it saw a resilient performance through lockdowns and a robust recovery in second half. For 2020, revenue increases by 12% to GBP49.3 million from GBP44.0 million in 2019 and pretax profit increases to GBP3.7 million from GBP3.3 million. Franchise Brands ups final dividend to 0.80p per share from 0.65p paid in 2019.

----------

ThinkSmart, up 6.7% at 77.9p, 12-month range 12p-91.5p. The digital payments business posts rise in interim earnings. For six months to December 31, pretax profit surges to GBP53.7 million from GBP16.0 million after financial instruments gains. ThinkSmart pays 3.4p per share special dividend and capital return in December.

----------

AIM - LOSERS

----------

MediaZest, down 16% at 0.080p, 12-month range 0.01p-0.18p. The audio-visual company says financial results for the eighteen-month period were affected substantially by the Covid-19 pandemic, with reduction in revenue particularly during the first UK lockdown. Revenue GP3.1 million, down from GBP3.3 million year before and swings to GBP478,000 pretax loss from GBP6,000 profit.

----------

Angle, down 9.7% at 79.30p, 12-month range 37.15p-98p. The liquid biopsy company says it has received response from US Food & Drug Administration after requesting clearance for its Parsortix treatment. Says FDA has indicated its review processes for non Covid-19 devices are currently slower than usual due to pandemic priorities. Notes that FDA processes are outside the company's control and it is continuing to expedite all aspects of the process which are under its control in line with previously advised timescales.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Jun 2010 08:56

Futura Medical Signs Development Deal With GlaxoSmithKline

LONDON (Dow Jones)--Pharmaceutical company Futura Medical PLC (FUM.LN) Tuesday said it signed a deal with GlaxoSmithKline PLC's (GSK.LN) cosumer healthcare unit to develop a painkiller. GlaxoSmithKline will be responsible for the clinical and regulatory development of Futura's TR100 and Futura w

Read more
12 May 2010 12:36

Small caps round-up: Aurelian, Cineworld, Greggs...

Eastern Europe focused oil and gas explorer and producer Aurelian today reconfirmed "steady" progress against all targets set out in October's strategy document. "We are on track to spud our first two high impact wells in line with our milestones; in June we commence the drilling of the first multi

Read more
2 Mar 2010 12:38

Small caps round-up: Share, Jetion Solar, Futura Medical...

Share, parent company of retail stockbroker The Share Centre, lifted profits last year to £2.35m from £1.46m on turnover of £14.1m, up from £12m. There was a significant increase in retail investor activity - especially online with deal volumes up by 75% on 2008, Share said. The interim dividend is

Read more
16 Dec 2009 08:43

Futura a step closer to TPR100 deal

Consumer healthcare product developer Futura Medical is in talks with a major pharmaceutical company on a licensing deal for its pain relief product, TPR100. The company interested in licensing TPR100 is the same one with which Futura announced an evaluation agreement in July 2009. Futura has rece

Read more
12 Nov 2009 14:32

Small caps round-up: Syntopix, Atlantic Coal, Brady...

Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acneic skin. Following the results, Syntopix has decided to focus its development efforts around three specific core compounds: SYN0126, SYN1113 and SYN

Read more
10 Nov 2009 09:22

Production changes in line for Futura condom

Futura Medical said a number of potential improvements to the production process of its ‘erectogenic’ condom have been identified by Durex condom maker SSL International. The proposed changes to the manufacturing process at SSL’s manufacturing facility in India have the potential to improve product

Read more
23 Sep 2009 13:10

Small caps round-up: Lifeline Scientific, Autologic, Bond...

The market liked Lifeline Scientific's maiden interim operating profit of $73,000 versus last year's loss of $3.1m, as the sale of 11 new LifePort kidney transporters helped revenue jump 123% to $7.75m. 'Trading was in-line with management's expectations during the first half and the board is confi

Read more
20 Jul 2009 08:35

Small caps round-up: Abbeycrest, Synchronica, Futura...

Jewellery maker Abbeycrest said it is performing in line with expectations as it undergoes a turnaround plan. The unbranded jewellery business is delivering much improved results on a significantly reduced turnover, the firm said. The brands division is making good progress with its higher margin b

Read more
10 Jun 2009 08:27

Small caps round-up: Intelligent Environments, LPA Group, Mobile Streams...

Banking software firm Intelligent Environments said trading in the current year to date has been robust. The group said it has experienced strong demand from new and existing customers to launch platforms to attract and retain retail deposits online. "Our strategy to develop a long term recurring r

Read more
13 May 2009 09:20

Small caps round-up: H&T Group, China Medical, Fyffes...

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate. "The principal reason for the strong performance is the sustained go

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.